Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
Authors
Keywords
THC, Cannabidiol, Adolescence, Schizophrenia, Animal model, Neurodevelopment
Journal
PHARMACOLOGICAL RESEARCH
Volume 174, Issue -, Pages 105938
Publisher
Elsevier BV
Online
2021-10-15
DOI
10.1016/j.phrs.2021.105938
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: modulation of inflammatory pathways
- (2021) Eva Florensa-Zanuy et al. BIOCHEMICAL PHARMACOLOGY
- Detrimental effects of adolescent escalating low‐dose Δ 9 ‐tetrahydrocannabinol lead to a specific bio‐behavioural profile in adult male rats
- (2021) Nafsika Poulia et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments
- (2021) Marco Aurélio Mori et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis
- (2021) Sarah Kanana Kiburi et al. Substance Abuse
- Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
- (2021) Cássio Morais Loss et al. Frontiers in Pharmacology
- Gene Transfer Therapy for Neurodevelopmental Disorders
- (2021) Can Ozlu et al. DEVELOPMENTAL NEUROSCIENCE
- Cannabidiol modulation of hippocampal glutamate in early psychosis
- (2021) Aisling O’Neill et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum
- (2021) João F.C. Pedrazzi et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
- (2021) F. Markus Leweke et al. Frontiers in Pharmacology
- Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
- (2021) Francesco Bartoli et al. Journal of Clinical Medicine
- Cannabidiol for at risk for psychosis youth: A randomized controlled trial
- (2021) G. Paul Amminger et al. Early Intervention in Psychiatry
- From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia
- (2021) Kurt Leroy Hoffman Frontiers in Psychiatry
- News Feature: Cannabis and the adolescent brain
- (2020) Helen Shen PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
- (2020) Nicholas Keks et al. CNS DRUGS
- Cross-Generational THC Exposure Alters Heroin Reinforcement in Adult Male Offspring
- (2020) Briana J. Hempel et al. DRUG AND ALCOHOL DEPENDENCE
- Δ-9-Tetrahydrocannabinol treatment during adolescence and alterations in the inhibitory networks of the adult prefrontal cortex in mice subjected to perinatal NMDA receptor antagonist injection and to postweaning social isolation
- (2020) Clara Garcia-Mompo et al. Translational Psychiatry
- Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
- (2020) Zsolt Gáll et al. Biomolecules
- CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim
- (2020) Amanda J. Sales et al. BEHAVIOURAL BRAIN RESEARCH
- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
- (2020) Tibor Stark et al. BIOCHEMICAL PHARMACOLOGY
- Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors
- (2020) Danilo De Gregorio et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Deleterious Effects of Ethanol, Δ(9)-Tetrahydrocannabinol (THC), and Their Combination on the Spatial Memory and Cognitive Flexibility in Adolescent and Adult Male Rats in the Barnes Maze Task
- (2020) Ewa Gibula-Tarlowska et al. Pharmaceutics
- Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models
- (2020) Ariel L. Dunn et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
- (2020) Grace Blest-Hopley et al. Frontiers in Psychiatry
- Adolescent Marijuana Use in the United States and Structural Breaks: An Age-Period-Cohort Analysis, 1991 to 2018
- (2020) Jiaxin Gu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
- (2020) Martina Di Bartolomeo et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
- (2020) María S. García-Gutiérrez et al. Biomolecules
- Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue
- (2020) Jan Kucera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment
- (2019) Ester Aso et al. MOLECULAR NEUROBIOLOGY
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- (2019) Robert A. McCutcheon et al. TRENDS IN NEUROSCIENCES
- Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood
- (2019) Andrew R. Abela et al. PSYCHOPHARMACOLOGY
- New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
- (2019) Suman Chandra et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample
- (2019) Kenneth S. Kendler et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood
- (2019) Adriaan W. Bruijnzeel et al. PSYCHOPHARMACOLOGY
- Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders
- (2019) Ashleigh L. Osborne et al. BRAIN BEHAVIOR AND IMMUNITY
- Chronic adolescent exposure to ∆9-tetrahydrocannabinol decreases NMDA current and extrasynaptic plasmalemmal density of NMDA GluN1 subunits in the prelimbic cortex of adult male mice
- (2019) Virginia M. Pickel et al. NEUROPSYCHOPHARMACOLOGY
- Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats
- (2019) Eva Drazanova et al. Scientific Reports
- Measuring Disturbance of the Endocannabinoid System in Psychosis
- (2019) Amedeo Minichino et al. JAMA Psychiatry
- Escalating low‐dose Δ 9 ‐tetrahydrocannabinol exposure during adolescence induces differential behavioral and neurochemical effects in male and female adult rats
- (2019) Nafsika Poulia et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
- (2019) Vincenzo Di Marzo et al. Nutrients
- Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins
- (2019) Aintzane García-Bea et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use
- (2019) Grace Blest-Hopley et al. PSYCHOPHARMACOLOGY
- A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol
- (2019) Cinzia Citti et al. Scientific Reports
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endocannabinoid system, Stress and HPA axis
- (2018) Vincenzo Micale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
- (2018) Amanda J. Sales et al. MOLECULAR NEUROBIOLOGY
- Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells
- (2018) Liliana Galindo et al. MOLECULAR NEUROBIOLOGY
- Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
- (2018) Inés Ibarra-Lecue et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- (2018) Amanda J. Sales et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Cannabidiol effects on prepulse inhibition in nonhuman primates
- (2018) Patricia G. Saletti et al. REVIEWS IN THE NEUROSCIENCES
- Recent advances in the prevention of mental disorders
- (2018) Tamar Mendelson et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults
- (2018) J. Cobb Scott et al. JAMA Psychiatry
- Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation
- (2018) Yue-min Bian et al. ACTA PHARMACOLOGICA SINICA
- Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB–Cyclooxygenase-2 Signaling to Impair Memory in Adulthood
- (2018) Yan Jouroukhin et al. BIOLOGICAL PSYCHIATRY
- GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
- (2018) Joëlle A. Pasman et al. NATURE NEUROSCIENCE
- Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
- (2018) Celia J. A. Morgan et al. Translational Psychiatry
- Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
- (2018) Fernanda F. Peres et al. Frontiers in Pharmacology
- Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood
- (2018) Rocio Saravia et al. NEUROPHARMACOLOGY
- Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors
- (2018) Hanna J. Szkudlarek et al. NEUROPSYCHOPHARMACOLOGY
- Effects of cannabidiol in males and females in two different rat models of depression
- (2018) Liat Shbiro et al. PHYSIOLOGY & BEHAVIOR
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction
- (2017) Hadar Segal-Gavish et al. HUMAN MOLECULAR GENETICS
- HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals
- (2017) Josef Večeřa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus
- (2017) Vincenzo Micale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Evidence for the Risks and Consequences of Adolescent Cannabis Exposure
- (2017) Amir Levine et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
- (2017) Ashleigh L Osborne et al. NEUROPSYCHOPHARMACOLOGY
- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
- (2017) Justine Renard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia
- (2017) Jana Ruda-Kucerova et al. NEUROTOXICITY RESEARCH
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE)
- (2017) Livio Luongo et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
- (2017) Renata Androvicova et al. PHARMACOLOGICAL RESEARCH
- Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice
- (2017) Guadalupe Rodríguez et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension
- (2017) Neal R. Swerdlow et al. SCHIZOPHRENIA RESEARCH
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens
- (2017) Meghan E. Morean et al. SUBSTANCE USE & MISUSE
- Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function
- (2017) Justine Renard et al. Scientific Reports
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis
- (2016) Liana Fattore BIOLOGICAL PSYCHIATRY
- Association Between Cannabis and Psychosis: Epidemiologic Evidence
- (2016) Suzanne H. Gage et al. BIOLOGICAL PSYCHIATRY
- Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway
- (2016) Justine Renard et al. JOURNAL OF NEUROSCIENCE
- Phytocannabinoids: a unified critical inventory
- (2016) Lumír Ondřej Hanuš et al. NATURAL PRODUCT REPORTS
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Prohedonic Effect of Cannabidiol in a Rat Model of Depression
- (2016) Gal Shoval et al. NEUROPSYCHOBIOLOGY
- Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
- (2016) Marco Colizzi et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal
- (2016) Lindsay Silva et al. NEUROTOXICOLOGY AND TERATOLOGY
- Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats
- (2016) Erica Zamberletti et al. PHARMACOLOGICAL RESEARCH
- Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
- (2016) F.F. Peres et al. SCHIZOPHRENIA RESEARCH
- Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
- (2016) Jana Ruda-Kucerova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study
- (2016) Laura Koenders et al. PLoS One
- MK-801-induced deficits in social recognition in rats
- (2015) Serena Deiana et al. BEHAVIOURAL PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats
- (2015) Erica Zamberletti et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects
- (2015) Matthew J. Smith et al. HIPPOCAMPUS
- Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing
- (2015) Jeffrey C. Raber et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory
- (2015) Michael D. Ballinger et al. NEUROBIOLOGY OF DISEASE
- Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex
- (2015) Tiziana Rubino et al. NEUROBIOLOGY OF DISEASE
- Adolescent Δ9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats
- (2015) Maria Scherma et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
- (2015) J. F. C. Pedrazzi et al. PSYCHOPHARMACOLOGY
- 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
- (2015) Alvaro Llorente-Berzal et al. PSYCHOPHARMACOLOGY
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
- (2015) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- Neural processing of reward in adolescent rodents
- (2015) Nicholas W. Simon et al. Developmental Cognitive Neuroscience
- Cortical Thickness and Neurocognition in Adolescent Marijuana and Alcohol Users Following 28 Days of Monitored Abstinence
- (2015) Joanna Jacobus et al. Journal of Studies on Alcohol and Drugs
- The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia
- (2014) Lakshmi Rajagopal et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice
- (2014) Ana Luisa B. Terzian et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions
- (2014) Livio Luongo et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study
- (2014) Tim Ziermans et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Long-Term Effects of Cannabis on Brain Structure
- (2014) Giovanni Battistella et al. NEUROPSYCHOPHARMACOLOGY
- Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction
- (2014) Michael Loureiro et al. NEUROPSYCHOPHARMACOLOGY
- Longitudinal four-dimensional mapping of subcortical anatomy in human development
- (2014) A. Raznahan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats
- (2013) Cristina Cadoni et al. ADDICTION BIOLOGY
- Leading compounds for the validation of animal models of psychopathology
- (2013) Vincenzo Micale et al. CELL AND TISSUE RESEARCH
- Anhedonia, avolition, and anticipatory deficits: Assessments in animals with relevance to the negative symptoms of schizophrenia
- (2013) Samuel A. Barnes et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Prepulse inhibition in psychiatric disorders – Apart from schizophrenia
- (2013) S. Kohl et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The contextual brain: implications for fear conditioning, extinction and psychopathology
- (2013) Stephen Maren et al. NATURE REVIEWS NEUROSCIENCE
- Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats
- (2013) Erica Zamberletti et al. NEUROBIOLOGY OF DISEASE
- Accelerated Experience-Dependent Pruning of Cortical Synapses in Ephrin-A2 Knockout Mice
- (2013) Xinzhu Yu et al. NEURON
- Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity
- (2013) Staci A. Gruber et al. PSYCHOPHARMACOLOGY
- Maternal high-fat diet in mice programs emotional behavior in adulthood
- (2012) Daria Peleg-Raibstein et al. BEHAVIOURAL BRAIN RESEARCH
- Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence
- (2012) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats
- (2012) Anand Gururajan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Decision-making in the adolescent brain
- (2012) Sarah-Jayne Blakemore et al. NATURE NEUROSCIENCE
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- (2012) Leonora E. Long et al. PLoS One
- Persistent cannabis users show neuropsychological decline from childhood to midlife
- (2012) M. H. Meier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sex-dependent effects of early maternal deprivation on MDMA-induced conditioned place preference in adolescent rats: Possible neurochemical correlates
- (2012) Alvaro Llorente-Berzal et al. TOXICOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabis use before age 15 and subsequent executive functioning
- (2011) Maria Alice Fontes et al. BRITISH JOURNAL OF PSYCHIATRY
- Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats
- (2011) E. Zamberletti et al. NEUROSCIENCE
- Involvement of opioid system in cognitive deficits induced by ∆9-tetrahydrocannabinol in rats
- (2011) Nobuaki Egashira et al. PSYCHOPHARMACOLOGY
- The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia
- (2011) V. C. Leeson et al. SCHIZOPHRENIA BULLETIN
- Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence
- (2011) Tim B. Ziermans et al. SCHIZOPHRENIA RESEARCH
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
- (2011) Ana Luisa Terzian et al. Frontiers in Behavioral Neuroscience
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats
- (2010) N. Realini et al. NEUROPHARMACOLOGY
- Chronic Adolescent Exposure to Δ-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Psychosis-Related and Other Phenotypes
- (2010) Colm MP O'Tuathaigh et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat
- (2010) Lauren C. Harte et al. NEUROTOXICOLOGY AND TERATOLOGY
- Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
- (2010) Matthijs G. Bossong et al. PROGRESS IN NEUROBIOLOGY
- Chronic use of cannabis and poor neural efficiency in verbal memory ability
- (2010) Robert A. Battisti et al. PSYCHOPHARMACOLOGY
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
- (2009) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex
- (2009) T. Rubino et al. NEUROTOXICITY RESEARCH
- Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
- (2009) M. van den Buuse SCHIZOPHRENIA BULLETIN
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use
- (2008) Manzar Ashtari et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Why do many psychiatric disorders emerge during adolescence?
- (2008) Tomáš Paus et al. NATURE REVIEWS NEUROSCIENCE
- Corpus callosum damage in heavy marijuana use: Preliminary evidence from diffusion tensor tractography and tract-based spatial statistics
- (2008) D. Arnone et al. NEUROIMAGE
- Chronic Δ9-Tetrahydrocannabinol During Adolescence Provokes Sex-Dependent Changes in the Emotional Profile in Adult Rats: Behavioral and Biochemical Correlates
- (2008) Tiziana Rubino et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now